
ScinoPharm Taiwan Ltd
TWSE:1789

Intrinsic Value
The intrinsic value of one
ScinoPharm Taiwan Ltd
stock under the Base Case scenario is
18.49
TWD.
Compared to the current market price of 22.95 TWD,
ScinoPharm Taiwan Ltd
is
Overvalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
ScinoPharm Taiwan Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
ScinoPharm Taiwan Ltd
Balance Sheet Decomposition
ScinoPharm Taiwan Ltd
Current Assets | 6.7B |
Cash & Short-Term Investments | 4.2B |
Receivables | 494.2m |
Other Current Assets | 2B |
Non-Current Assets | 5.3B |
Long-Term Investments | 80.3m |
PP&E | 4.6B |
Intangibles | 18.3m |
Other Non-Current Assets | 634.9m |
Free Cash Flow Analysis
ScinoPharm Taiwan Ltd
TWD | |
Free Cash Flow | TWD |
Earnings Waterfall
ScinoPharm Taiwan Ltd
Revenue
|
3.5B
TWD
|
Cost of Revenue
|
-2.1B
TWD
|
Gross Profit
|
1.4B
TWD
|
Operating Expenses
|
-934.3m
TWD
|
Operating Income
|
446.4m
TWD
|
Other Expenses
|
-47m
TWD
|
Net Income
|
399.4m
TWD
|
Profitability Score
Profitability Due Diligence
ScinoPharm Taiwan Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
ScinoPharm Taiwan Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
ScinoPharm Taiwan Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Score
ScinoPharm Taiwan Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
ScinoPharm Taiwan Ltd
Dividends
Current shareholder yield for ScinoPharm Taiwan Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ScinoPharm Taiwan Ltd
stock under the Base Case scenario is
18.49
TWD.
Compared to the current market price of 22.95 TWD,
ScinoPharm Taiwan Ltd
is
Overvalued by 19%.